Also listed on ResMed (R&D) Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 20, 2026 · High confidence
20-year base term ended Feb 20, 2024
Held by ResMed Pty Ltd.
Filed Jun 8, 2018 as application 16/003,341 · Granted Nov 15, 2022
Base term plus 1004 days of patent term adjustment (USPTO delay)
Today
2004
2026
Clock starts
Feb 20, 2004
Feb 20, 2004
Term ends
Nov 20, 2026
Nov 20, 2026
Granted
Nov 15, 2022
Nov 15, 2022
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,004
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
23
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1004 days past its 20-year base term on prosecution delay. 1 of 1 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 20, 2004, when application 10/781,929, the earliest non-provisional in its chain, was filed (this one was filed Jun 8, 2018) | Feb 20, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1004 days, USPTO patent term adjustment record | Nov 20, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 20, 2026 | High confidence |
This family
| US 7,318,437 | Term ended Apr 2026 | Apr 2026 |
| US 7,461,656 | Term ended no later than Feb 2024 | no later than Feb 2024 |
| US 8,186,352 | In force Mar 2027 | Mar 2027 |
| US 8,042,546 | Term ended Oct 2026 | Oct 2026 |
| Application 11/962,621 | Abandoned not computed | not computed |
| US 8,312,881 | In force Jan 2027 | Jan 2027 |
| US 8,312,883 | In force Jul 2027 | Jul 2027 |
| US 8,286,636 | Lapsed on the fee record Oct 2024 | Oct 2024 |
8 of 23 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 11, 2018 Reel 46041, frame 938 | Kwok, Philip Rodney; Hitchcock, Robin Garth; Veliss, Lee James; Guney, Memduh; Lithgow, Perry David; Darkin, Donald; Lynch, Susan Robyn | ResMed (R&D) Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46041, frame 987 | Kwok, Philip Rodney; Hitchcock, Robin Garth; Veliss, Lee James; Guney, Memduh; Lithgow, Perry David; Darkin, Donald; Lynch, Susan Robyn | ResMed Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46042, frame 199 | Gunaratnam, Michael Kassipillai | ResMed (R&D) Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46042, frame 245 | Gunaratnam, Michael Kassipillai | ResMed Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46042, frame 347 | Sokolov, Richard | ResMed (R&D) Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46042, frame 416 | Sokolov, Richard | ResMed Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46042, frame 487 | ResMed (R&D) Limited | ResMed Limited | Assignment of Assignor's Interest |
| Jun 11, 2018 Reel 46333, frame 246 | ResMed Limited | ResMed Limited | Change of Assignee Address |
| Feb 22, 2019 Reel 48413, frame 440 | ResMed Limited | ResMed Pty Ltd. | Entity Conversion |
| Mar 5, 2019 Reel 48539, frame 540 | ResMed Limited | ResMed Ltd. Pty | Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 048413 Frame: 0440. Assignor(S) Hereby Confirms the Assignment. |
| Mar 26, 2019 Reel 48701, frame 84 | ResMed Limited | ResMed Pty Ltd. | Corrective Assignment to Correct the Assignee Name from Resmed LTD Pty to Resmed Pty LTD Previously Recorded on Reel 048539 Frame 0540. Assignor(S) Hereby Confirms the Entity Conversion to Resmed Pty LTD. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2026
Term ends Nov 20, 2026. No further fees fall due before then
Note
The 1004 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
10
later US patents cite this one
That is top 25% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.